{
  "3329198": "===============================================\nBRONCHOSCOPY PROCEDURE REPORT\n===============================================\nPatient: [REDACTED]\nMRN: [REDACTED]\nDOB: [REDACTED]\nDate: [REDACTED]\nPhysician: Sarah Chen, MD\n===============================================\n\n[INDICATION]\nPrimary: Lung nodule evaluation with mediastinal lymphadenopathy workup\nCategory: Lung Cancer Staging\nTarget: 30.2mm Ground-glass lesion, LUL inferior lingula (B5)\nBronchus Sign: Positive\nPET SUV: N/A\n\n[ANESTHESIA]\nType: General endotracheal anesthesia\nASA Class: 4\nAirway: 8.0mm ETT\nDuration: 98 minutes\n\n[DESCRIPTION]\nProcedure 1: Linear EBUS-TBNA\n- Scope: Olympus BF-UC190F\n- Needle: 22G Acquire\n- Stations sampled: 4R, 2R, 2L, 10L\n- Number of stations: 4 (â‰¥3)\n- ROSE available: Yes\n- ROSE result: Atypical cells\n\nProcedure 2: Robotic Bronchoscopy\n- Platform: Monarch (Auris Health (J&J))\n- Registration: CT-to-body, error 2.2mm\n- Target: LUL inferior lingula (B5)\n\nProcedure 3: Radial EBUS\n- View: Eccentric\n- Confirmation: CBCT\n\nProcedure 4: Transbronchial Biopsy\n- Forceps biopsies: 8\n- TBNA passes: 4\n- Brushings: 2\n- ROSE result: Malignant - small cell carcinoma\n\nSpecimens: Cytology, cell block, surgical pathology, BAL cultures\nComplications: None\nEBL: <10mL\n\n[PLAN]\n1. Post-procedure monitoring x2 hours\n2. Chest X-ray - completed, no pneumothorax\n3. Discharge to home if stable\n4. Follow-up: 1-2 weeks for pathology\n5. Tumor board review pending final results\n6. Molecular testing if malignancy confirmed\n\n===============================================\nElectronically signed: Sarah Chen, MD\nDate: [REDACTED]\n==============================================="
}
